Australian Health Experts Propose Keeping Puberty Blockers as a Clinical Option for Some Young People
Published
Australia's National Health and Medical Research Council (NHMRC) has released proposed advice on the use of puberty blockers. The advice recommends that these medicines remain a clinical option for some young people who experience gender incongruence, which means a difference between their gender identity and the sex they were assigned at birth.
Puberty blockers are medicines that delay the physical changes of puberty. Doctors may prescribe them to young people in certain situations, and the NHMRC's proposal suggests they should only be used under clinical guidance. This means that decisions about treatment would be made with medical professionals rather than being used without proper assessment and oversight.
The proposed advice is part of a wider discussion about how best to support young people who are experiencing gender incongruence. Health experts continue to review the evidence on these treatments, and the topic remains an important and sensitive issue for families, doctors and policymakers.
The NHMRC's advice is still in draft form, which means it has not yet been finalised. Members of the public and other groups may have the chance to comment before a final decision is made. Readers in New Zealand who want to follow this topic may wish to check official health sources for updates.
Sources: YOUR EX
More New Zealand news
- One NZ Launches Nature Tech Fund to Support Conservation Projects
- Prime Minister Luxon Heads to China for APEC as Technology Takes Centre Stage
- Reserve Bank Warns That an AI Bubble Burst Could Affect More Than KiwiSaver
- Parties Urged to Find Stable Government Rather Than Call a New Election
- NZ Spy Agency Warns of Foreign States Targeting Insiders Amid Nvidia Scandal
- New Zealand to Cover Any Extra Costs for Cook Islands Penrhyn Port Upgrade
- New Zealand Fresh Produce Exports Reach Record $7.32 Billion
- Dunedin Hospital Crown Manager's $2,500 Daily Rate Extended